← Back to Search

Behavioural Intervention

Targeted Exercise Prescription for Cardiac Rehabilitation (PACE SETTER Trial)

Phase 2
Recruiting
Led By Quinn R Pack, MD
Research Sponsored by Baystate Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Agrees to attend cardiac rehabilitation at least twice a week
Agrees to attend at least 18 sessions of cardiac rehabilitation after randomization
Must not have
Permanent atrial fibrillation
Stable angina
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at end of cr up to 2 years follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing two exercise plans for older adults with heart disease. One plan has a set goal, while the other lets participants decide their effort level. The goal is to see which plan improves fitness and health outcomes better.

Who is the study for?
This trial is for older adults (60+) who've had a recent heart event like a heart attack, bypass surgery, or valve replacement and are eligible for cardiac rehab. They must live near Springfield, MA or Detroit, MI and commit to at least 18 rehab sessions.
What is being tested?
The study compares two exercise prescriptions in cardiac rehab: one based on graded exercise tests with target heart rate ranges (GXT-THRR), the other on perceived exertion levels (RPE). It also examines psychological feedback's impact on fitness.
What are the potential side effects?
There may not be direct side effects from the interventions as they involve different methods of prescribing exercise. However, participants should be aware of their physical limits during rehabilitation exercises to avoid potential strain or injury.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I agree to go to cardiac rehab at least twice a week.
Select...
I agree to attend 18 or more cardiac rehab sessions after being selected.
Select...
I am 60 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a constant irregular heartbeat.
Select...
My chest pain is consistent and manageable.
Select...
I have pain in my legs due to poor blood flow.
Select...
I have had a heart transplant.
Select...
I have severe heart artery blockage that hasn't been treated with surgery.
Select...
I have a narrowing in my heart's aortic or mitral valve.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at end of cr up to 2 years follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and at end of cr up to 2 years follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Functional Fitness
Secondary study objectives
Change in functional fitness at 6 months
Change in physical performance at 6 months
Short Physical Performance Battery
+1 more
Other study objectives
Admission to the hospital (full admission or observation status) with apparent life-threatening illness
Change in 7-day % time in Moderate to Vigorous Physical Activity
Change in Quality of Life
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GXT+ THHR (intervention)Experimental Treatment1 Intervention
Patients assigned to the intervention group will complete a GXT approximately one week later and ideally prior to the 4th cardiac rehabilitation session. Resting and peak heart rate from the GXT will be recorded and used to calculate a target heart rate range (THRR) using the Karvonen formula (60-85% Heart rate reserve). After the test, they will receive psychoeducational feedback (PF) about their test results and exercise performance. After the PF, we will discuss the THRR and how it will be used to guide exercise intensity in CR. Patients in the intervention group will use their THHR to adjust their exercise intensity. For the first 6 cardiac rehabilitation sessions, patients will receive feedback about heart rate from the PolarHR monitor, research staff and CR staff when available. The goal is for patients to exercise in THRR for the majority of each exercise session.
Group II: RPE (usual care)Active Control1 Intervention
Participants randomized to usual care (RPE) will not complete a GXT. They will instead be scheduled for an approximately 5-minute educational session (i.e., time/attention-matched control condition) where they will receive information about heart-healthy nutrition. This is standard care at both sites. Patients in the control group will follow standard exercise prescription protocols in CR. This will include a baseline exercise assessment on exercise equipment in the gym (e.g., treadmill, elliptical, rower, NuStep, and/or stationary bicycle) as appropriate. Based on exercise levels achieved on the first day, patients will be given exercise recommendations for their 2nd session of CR and so forth. Participants will be asked to exercise at a moderate intensity RPE level at both sites. As the patients progress in CR, patients will increase their time, intensity, and mode of exercise guided by RPE and clinical assessment.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Exercise-based treatments for heart attack patients, such as the Graded Exercise Test + Target Heart Rate Range (GXT-THRR) and Rating of Perceived Exertion (RPE), work by improving cardiovascular fitness, enhancing heart function, and promoting overall physical health. GXT-THRR involves a personalized exercise plan based on a graded exercise test, which helps to determine the optimal heart rate range for safe and effective workouts. This method ensures that patients exercise at an intensity that maximizes cardiovascular benefits while minimizing risks. RPE, on the other hand, allows patients to self-assess their exertion levels and adjust their exercise intensity accordingly. This approach empowers patients to listen to their bodies and avoid overexertion. Both methods are crucial for heart attack patients as they help to strengthen the heart, improve blood flow, and reduce the likelihood of future cardiac events, ultimately enhancing recovery and long-term health outcomes.

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyOTHER
443 Previous Clinical Trials
65,422 Total Patients Enrolled
Springfield CollegeOTHER
9 Previous Clinical Trials
2,617 Total Patients Enrolled
University of PennsylvaniaOTHER
2,066 Previous Clinical Trials
42,712,589 Total Patients Enrolled

Media Library

GXT+THHR (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05925634 — Phase 2
Heart Attack Research Study Groups: RPE (usual care), GXT+ THHR (intervention)
Heart Attack Clinical Trial 2023: GXT+THHR Highlights & Side Effects. Trial Name: NCT05925634 — Phase 2
GXT+THHR (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05925634 — Phase 2
~171 spots leftby Feb 2026